Clinical Trial Update: Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ipilimumab plus etoposide and platinum to etoposide and platinum alone in extensive-disease small cell lung cancer has completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Etoposide (Etoposide)
• ipilimumab (ipilimumab)
• platinum therapy

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Small Cell Lung Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2016-07-18